2-(4-Chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid

Catalog No. :
ACVPMZ317
CAS No. :
351996-53-7
Molecular Formula :
C6H6ClN3O4
Molecular Weight :
219.58

IUPAC Name:2-(4-chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid

2-(4-Chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$311.00Login to see priceInquiryInquiry
5g95%$913.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid
IUPAC Name2-(4-chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid
MDL No.MFCD01234201
Molecular FormulaC6H6ClN3O4
Molecular Weight219.58
SMILESO=C(O)CN1N=C([N+]([O-])=O)C(Cl)=C1C
InChI KeyARQFVRQZKJYVKU-UHFFFAOYSA-N
Synonym(4-Chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid;Albb-006424;(4-chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)acetic acid(SALTDATA: FREE);(4-Chloro-5-methyl-3-nitro-pyrazol-1-yl)-acetic acid;2-(4-chloro-5-methyl-3-nitro-1-pyrazolyl)acetic acid;2-(4-chloro-5-methyl-3-nitro-pyrazol-1-yl)acetic acid;2-(4-chloro-5-methyl-3-nitropyrazol-1-yl)acetic acid;2-(4-chloro-5-methyl-3-nitro-pyrazol-1-yl)ethanoic acid
CAS No.351996-53-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACVPMZ317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVPMZ317 route product structure diagram
    ACVPMZ317351996-53-7
Inquiry

2. ACVPMZ317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVPMZ317 route product structure diagram
    ACVPMZ317351996-53-7
Inquiry

Comments (0)